News
1d
Stockhead on MSNScott Power: ASX health stocks fall in roller coast week; Monash falls on embryo mix-upASX health stocks fall with Morgans Scott Power noting Trump's on-again, off-again Liberation Tariffs sending shock waves ...
Finn Whittacre said she does not remember when her heart stopped for seven minutes that January day. But the Las Vegas Academy of the Arts faculty and staff who saved her life will never forget it.
Rocket Pharmaceuticals' gene therapies offer long-term effects for cardiovascular and hematology diseases. Read why I rate ...
The direct oral anticoagulant is an effective alternative to warfarin that offers predictable dosing without the need for ...
Resonant Link Medical develops wireless power charging and data transfer technology for implants as they get smarter and ...
The New Mexico Heart Institute has participated in a number of clinical studies over the years to bring better heart health ...
A team at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) has developed an innovative gene-therapy strategy ...
A team at CNIC has developed an innovative gene therapy to treat arrhythmogenic right ventricular cardiomyopathy type 5 ...
The risk for a blood clot in the left ventricle, the heart's main pumping chamber, is highest in the first three months after ...
The first clinical guidance for cardiogenic shock will be presented at the American College of Cardiology Scientific Session for a syndrome that still takes the lives of 1 in 3 patients.
“The AR view shows where the ventricles are so clinicians can decide on the best ... phase makes this whole project unique,” says Zahra Asadi, a PhD student and co-first author on the paper. “Working ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results